Literature DB >> 7773643

Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis.

J T Norman1, L Gatti, P D Wilson, M Lewis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7773643

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


× No keyword cloud information.
  7 in total

1.  Expression of profibrotic genes in a murine remnant kidney model.

Authors:  Binxia Yang; Pawan K Vohra; Rajiv Janardhanan; Khamal D Misra; Sanjay Misra
Journal:  J Vasc Interv Radiol       Date:  2011-10-26       Impact factor: 3.464

Review 2.  Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Jill Norman
Journal:  Biochim Biophys Acta       Date:  2011-07-01

3.  Vascular endothelial growth factor-A, matrix metalloproteinase-1, and macrophage migration inhibition factor changes in the porcine remnant kidney model: evaluation by magnetic resonance imaging.

Authors:  Sanjay Misra; Khamal D Misra; James F Glockner
Journal:  J Vasc Interv Radiol       Date:  2010-07       Impact factor: 3.464

4.  Matrix Metalloproteinase 20 Co-expression With Dentin Sialophosphoprotein in Human and Monkey Kidneys.

Authors:  Kalu U E Ogbureke; Komal Koli; Geetu Saxena
Journal:  J Histochem Cytochem       Date:  2016-10       Impact factor: 2.479

5.  Doxycycline accelerates renal cyst growth and fibrosis in the pcy/pcy mouse model of type 3 nephronophthisis, a form of recessive polycystic kidney disease.

Authors:  Larissa Osten; Marion Kubitza; Anna Rachel Gallagher; Jürgen Kastner; Heike Olbrich; Uwe de Vries; Frieder Kees; Brigitte Lelongt; Stefan Somlo; Heymut Omran; Ralph Witzgall
Journal:  Histochem Cell Biol       Date:  2009-04-21       Impact factor: 4.304

6.  Pkd1 inactivation induced in adulthood produces focal cystic disease.

Authors:  Ayumi Takakura; Leah Contrino; Alexander W Beck; Jing Zhou
Journal:  J Am Soc Nephrol       Date:  2008-09-05       Impact factor: 10.121

7.  Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease.

Authors:  Michelle Da Silva Lodge; Nick Pullen; Miguel Pereira; Timothy S Johnson
Journal:  PLoS One       Date:  2022-01-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.